Greetings from Day 2 of the CHDI HD Therapeutics Conference! HDBuzz continues to provide summaries of the exciting talks from HD scientists gathered in Palm Springs from around the world. This day’s ...
In plain language. Written by scientists. For the global HD community.
10 min read | The FDA wants more data before approving AMT-130 for Huntington’s disease in the U.S. On March 2026, uniQure ...
Your brain is the most advanced supercomputer in the world. But in Huntington’s disease (HD), a core processor of this computer starts to malfunction. Using advanced imaging techniques, a research ...
When caring for people affected by Huntington’s disease (HD), doctors often face major challenges due to the lack of precise tools to track how the disease progresses or to predict exactly when a ...
Skyhawk Therapeutics announced on March 3, 2026 that Australia’s Therapeutic Goods Administration (TGA) has determined that SKY-0515, an small molecule drug that can be taken as a pill to lower ...
In a press release from February 24th, 2026, Vico Therapeutics have announced that participants are now being dosed in a new fourth arm of their ongoing Phase 1/2a clinical trial of VO659, a drug ...
February is the shortest month, but the HD research community packed a lot into it. From peer-reviewed trial data finally hitting the journals to fundamental discoveries about how brain cells are ...
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results